IFNA 抗体 (AA 24-181)
Our Local Distributor
北京 101111
Quick Overview for IFNA 抗体 (AA 24-181) (ABIN2296473)
抗原
See all IFNA 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 24-181
-
交叉反应
- 人
-
交叉反应 （详细）
- Calculated cross reactivity: Hu
-
产品特性
- Interferon Alpha (IFNa, IFNA1, IFL, IFN, IFN-Alpha, IFNA13, IFN-A, IFNAP22, IFN-Alpha 1b, Interferon Alpha 1b, Interferon, Leukocytic, IFN, Leukocyte)
-
纯化方法
- Purified by affinity chromatography.
-
免疫原
- Recombinant protein coresponding to aa24-181 from human IFNa with two N-terminal tags, His-tag and GST tag, expressed in E. coli
-
亚型
- IgG
-
-
anti-Interferon alpha (IFNA) (AA 28-227) antibody
IFNA 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) antibodyIFNA 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-192) antibodyIFNA 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-189) antibodyIFNA 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 1-187) antibodyIFNA 适用: 豚鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-181) antibodyIFNA 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) antibodyIFNA 适用: 大鼠 FACS 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-181) antibodyIFNA 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C3 unconjugated
anti-Interferon alpha (IFNA) (AA 47-191) antibodyIFNA 适用: 小鸡 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 23-187) antibodyIFNA 适用: 犬 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working conditions should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Supplied as a liquid in PBS, pH 7.2, 0.02 % sodium azide, 50 % glycerol.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- -20°C
-
-
- IFNA (Interferon alpha (IFNA))
-
别名
- Interferon alpha
-
途径
- JAK/STAT Signaling, TLR signaling, Hepatitis C, Inflammasome
抗原
-
